Enzymatica AB (Sweden) Profile

SEK 0.20  4.94%

Enzymatica AB Summary

Enzymatica AB (ENZY) is traded on Stockholm Stock Exchange in Sweden. It is located in Ideon Science Park and employs 21 people. The company currently falls under 'Small-Cap' category with current market capitalization of 404.45 M. Enzymatica AB operates under Healthcare sector and is part of Pharmaceuticals And Biosciences industry. This company has 90.89 M outstanding shares. ENZYMATICA has accumulated about 10.93 M in cash with (22.55 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.12.
Check Enzymatica AB Probability Of Bankruptcy

Enzymatica AB Risk Profiles

Key Fundamentals

Enzymatica AB Against Markets

Current Ratings

Enzymatica AB 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
Chance of
Financial Distress (0 to 100%)
< 2% 
Equity ratings for Enzymatica AB are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Enzymatica AB , a life science company, develops and sells medical device products against infectious-related diseases. The company was founded in 2007 and is headquartered in Lund, Sweden. Enzymatica AB operates under Pharmaceuticals And Biosciences classification in Sweden and traded on Stockholm Stock Exchange exchange. It employs 21 people. more
NameEnzymatica AB
Chairman of the BoardBengt BaronView All
Macroaxis Advice
Healthcare, Pharmaceuticals And Biosciences
InstrumentSweden Stock View All
Business AddressIdeon Science Park
Foreign Associate  USA
ExchangeStockholm Stock Exchange
IndustryPharmaceuticals And Biosciences
Contact Number46 4 62 86 31 00
CurrencySEK - Swedish Kronor

Diversify with Enzymatica AB

Build Optimal Portfolios
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Enzymatica AB to your portfolio


Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  


Enzymatica AB Corporate Directors
Jonas Forsberg Director, MBA
Anders Jungbeck Director
Nils Siegbahn Director, Ph.D